Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2441-2447

  Nicholas, B L ^a   Brennan, F R ^b   Hamilton, W D O ^c   Wakelin, D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b HUNTINGDON LIFE SCIENCES   (United Kingdom)

^c Babraham Hall   (United Kingdom)

Author keywords

Challenge; Chimaeric virus particle; Mucosal immunity; Priming

Indexed keywords

ASPARTYLGLYCYLALANYLVALYLGLUTAMINYLPROLYLASPARTYLGLYCYLGLYCYLGLUTAMINYLP ROL YLALANYLVALYLARGINYLASPARAGINYLGLUTAMYLARGININE; ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A; PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHIMERIC VIRUS PARTICLE CONSTRUCT; CONTROLLED STUDY; COWPEA; DRUG EFFECT; DRUG EXPOSURE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; INTESTINE; INTESTINE LAVAGE; LIQUID; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOSAIC VIRUS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PARVOVIRUS; PLANT VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SYSTEMIC CIRCULATION; TH1 CELL; VACCINATION; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS PARTICLE; WILD TYPE;

EID: 0037654986     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00054-9     Document Type: Article

References (19)

1. Usha R., Rohll J., Spall V.E., Shanks M., Maule A.J., Johnson J.E.et al. Expression of an animal virus antigenic on the surface of a plant virus particle. Virology. 197:1993;366-374.
2. Porta C., Spall V.E., Loveland J.E., Johnson J.E., Barker P.J., Lomonossoff G.P. Development of cow pea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology. 202:1994;949-955.
3. Dalsgaard K., Uttenthal A., Jones T.D., Xu F., Merryweather A.M., Hamilton W.D.O. Plant-derived vaccine protects target animals against a viral disease. Nat. Biotech. 15:1997;248-252.
4. Nicholas B.L., Brennan F.R., Martines-Torrecuadrada J.L., Casal J.I., Hamilton W.D., Wakelin D. Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses. Vaccine. 20:2002;2727-2734.
5. McInerney T.L., Brennan F.R., Jones T.D., Dimmock N.J. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide. Vaccine. 17:1999;1359-1368.
6. Brennan F.R., Jones T.D., Gilleland L.B., Bellaby T., Xu F., North P.C. Pseudomonas aeruginosa outer membrane protein F epitopes are highly immunogenic when expressed on a plant virus. Microbiology. 145:1999;211-220.
7. McLain L., Porta C., Lomonossoff G.P., Durrani Z., Dimmock N.J. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Res. Hum. Retroviruses. 11:1995;327-334.
8. Hou Y.C., Hu W.G., Hirano T., Gu X.X. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarhalis in a mouse challenge model. Vaccine. 20(17-18):2002;2375-2381.
9. Choi A.H., McNeal M.M., Flint J.A., Basu M., Lycke N.Y., Clements J.D.et al. The level of protection against rotavirus shedding in mice following immunisation with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Vaccine. 20(13-14):2002;1733-1740.
10. Finerty S., Stokes C.R., Gruffydd-Jones T.J., Hillman T.J., Reeves N.A., Whiting C.V.et al. Mucosal immunisation with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge. Vaccine. 18(28):2000;2354-2365.
11. Bernstein D.I. Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection. Vaccine. 18(14):2000;1351-1358.
12. Koo M., Bendahmane M., Lettieri G.A., Paoletti A.D., Lane T.E., Fitchen J.H.et al. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc. Natl. Acad. Sci. USA. 96(14):1999;7774-7779.
13. Brennan F.R., Bellaby T., Helliwell S.M., Jones T.D., Kamstrup S.K., Dalsgaard J. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J. Virol. 73:1999;930-938.
14. Karupiah G., Buller R.M., Van Rooijen N., Duarte C.J., Chen J. Different roles for CD4+ and CD8- T lymphocytes and macrophage substes in the control of a generalized virus infection. J. Virol. 70:1996;8301-8309.
15. Richards C.M., Shimeld C., Williams N.A., Hill T.J. Induction of mucosal immunity against herpes simplex virus type 1 in the mouse protects against ocular infection and establishment of latency. J. Infect. Dis. 177:1993;1451-1457.
16. Moran T.M., Isobe H., Fernandez-Sesma A., Schulman J.L. Interleukin-4 causes delayed virus clearance in influenza-infected mice. J. Virol. 70:1996;5230-5235.
17. Marinaro M, Kiyono H, Van Cott JL, Okahashi N, van Ginkel FW, Pascual DW, Ban E, Jackson RL, Staats H, McGhee J. Vaccines for selective induction of Th1- and Th2-cell responses and their roles in mucosal immunity. In: Kagnoff MF, Kiyono H, editors. Essentials of mucosal immunity. San Diego: Academic Press; 1996. p. 461-75.
18. Zhang Y.X., Pacheco S., Acuna C.L., Switzer K.C., Wang Y., Gilmore X.et al. Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus. Immunology. 105(3):2002;286-294.
19. LoMan R., Sedlik C., LeClerc C. Antigen presentation to Th1 and Th2 cells. Revue Francaise D'Allergologie et D'Immunologie Clinique. 35(6):1995;565-569.